{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:58:22Z","timestamp":1780610302100,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1124\/jpet.121.000689","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T17:45:19Z","timestamp":1625766319000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Antinociceptive and Discriminative Stimulus Effects of Six Novel Psychoactive Opioid Substances in Male Rats"],"prefix":"10.1016","volume":"379","author":[{"given":"Ellen A.","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew G.","family":"Korber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srihari R.","family":"Tella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Prioleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt A","key":"10.1124\/jpet.121.000689_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review","volume":"134","author":"Armenian","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.121.000689_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1476-5381.1959.tb00928.x","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br J Pharmacol Chemother"},{"issue":"Pt A","key":"10.1124\/jpet.121.000689_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuropharm.2017.08.016","article-title":"Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace","volume":"134","author":"Baumann","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.121.000689_bib4","doi-asserted-by":"crossref","first-page":"108110","DOI":"10.1016\/j.neuropharm.2020.108110","article-title":"In vitro and in vivo pharmacological characterization of the synthetic opioid MT-45","volume":"171","author":"Bilel","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.121.000689_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neulet.2018.04.009","article-title":"Rewarding and reinforcing effects of 4-chloro-2,5-dimethoxyamphetamine and AH-7921 in rodents","volume":"676","author":"Cha","year":"2018","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.121.000689_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0024-3205(92)90199-Y","article-title":"Opioid agonists binding and responses in SH-SY5Y cells","volume":"50","author":"Costa","year":"1992","journal-title":"Life Sci"},{"key":"10.1124\/jpet.121.000689_bib7","first-page":"107","article-title":"Discriminative and analgesic effects of mu and kappa opioids: in vivo pA2 analysis","volume":"4","author":"Dykstra","year":"1988","journal-title":"Psychopharmacol Ser"},{"key":"10.1124\/jpet.121.000689_bib8","series-title":"EMCDDA\u2013Europol Joint Report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (\u2018MT-45\u2019), Joint Reports","year":"2014"},{"key":"10.1124\/jpet.121.000689_bib9","series-title":"EMCDDA\u2013Europol Joint Report on a new psychoactive substance: AH-7921 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide, Joint Reports","year":"2014"},{"key":"10.1124\/jpet.121.000689_bib10","series-title":"EMCDDA\u2013Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (acetylfentanyl), Joint Reports","year":"2016"},{"key":"10.1124\/jpet.121.000689_bib11","doi-asserted-by":"crossref","first-page":"114293","DOI":"10.1016\/j.bcp.2020.114293","article-title":"Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors","volume":"182","author":"Eshleman","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.121.000689_bib12","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.forsciint.2017.04.003","article-title":"Two fatalities associated with synthetic opioids: AH-7921 and MT-45","volume":"277","author":"Fels","year":"2017","journal-title":"Forensic Sci Int"},{"key":"10.1124\/jpet.121.000689_bib14","unstructured":"Gon\u00e7alves J (2016) Notice to interested parties \u2014 Proposal regarding the scheduling of W-18 under the Controlled Drugs and Substances Act and its regulations, in (Health Do ed), Canada Gazette."},{"key":"10.1124\/jpet.121.000689_bib15","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/jm00257a012","article-title":"1-(3,4-Dichlorobenzamidomethyl)cyclohexyldimethylamine and related compounds as potential analgesics","volume":"17","author":"Harper","year":"1974","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.121.000689_bib16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1476-5381.1983.tb10011.x","article-title":"Determination of receptors that mediate opiate side effects in the mouse","volume":"79","author":"Hayes","year":"1983","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.121.000689_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11419-007-0039-1","article-title":"Studies on 1-(2-phenethyl)-4-(N-propionylanilino) piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues","volume":"26","author":"Higashikawa","year":"2008","journal-title":"Forensic Toxicol"},{"key":"10.1124\/jpet.121.000689_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1172\/jci.insight.97222","article-title":"Fentanyl-related designer drugs W-18 and W-15 lack appreciable opioid activity in vitro and in vivo","volume":"2","author":"Huang","year":"2017","journal-title":"JCI Insight"},{"key":"10.1124\/jpet.121.000689_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11419-015-0271-z","article-title":"AH-7921: the list of new psychoactive opioids is expanded","volume":"33","author":"Katselou","year":"2015","journal-title":"Forensic Toxicol"},{"key":"10.1124\/jpet.121.000689_bib20","series-title":"Analgesics substituted piperidylidens-2-sulfon(cyan)amide derivatives","author":"Knauss","year":"1984"},{"key":"10.1124\/jpet.121.000689_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jat\/bku057","article-title":"Fatal intoxications associated with the designer opioid AH-7921","volume":"38","author":"Kronstrand","year":"2014","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.121.000689_bib22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00213-007-0914-9","article-title":"Comparison of naltrexone, 6alpha-naltrexol, and 6beta-naltrexol in morphine-dependent and in nondependent rhesus monkeys","volume":"195","author":"Li","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.121.000689_bib23","first-page":"144","article-title":"Structure activity studies of two classes of beta-amino-amides: the search for kappa-selective opioids","volume":"90","author":"Loew","year":"1988","journal-title":"NIDA Res Monogr"},{"key":"10.1124\/jpet.121.000689_bib24","first-page":"105","article-title":"Comparative study of 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine and its enantiomorphs on analgesic and othe pharmacological activities in experimental animals","volume":"221","author":"Nakamura","year":"1976","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1124\/jpet.121.000689_bib25","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1021\/jm00210a017","article-title":"Studies on 1-substituted 4-(1,2-diphenylethyl)piperazine derivatives and their analgesic activities. 2. Structure-activity relationships of 1-cycloalkyl-4-(1,2-diphenylethyl)piperazines","volume":"21","author":"Natsuka","year":"1978","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.121.000689_bib26","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1021\/jm00393a017","article-title":"Synthesis and structure-activity relationships of 1-substituted 4-(1,2-diphenylethyl)piperazine derivatives having narcotic agonist and antagonist activity","volume":"30","author":"Natsuka","year":"1987","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.121.000689_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/FTD.0000000000000465","article-title":"Acute intoxications and fatalities From illicit fentanyl and analogues: an update","volume":"40","author":"Pichini","year":"2018","journal-title":"Ther Drug Monit"},{"key":"10.1124\/jpet.121.000689_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00008877-199605000-00001","article-title":"Opioids and rate of positively reinforced behavior: differential antagonism by naltrexone","volume":"7","author":"Pitts","year":"1996","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.121.000689_bib29","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1021\/acschemneuro.7b00075","article-title":"Reaching out for sensitive evaluation of the mu opioid receptor in vivo: positron emission tomography imaging of the agonist [11C]AH7921","volume":"8","author":"Rafique","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.121.000689_bib30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/08998280.2018.1465320","article-title":"AH-7921: a review of previously published reports","volume":"31","author":"Rambaran","year":"2018","journal-title":"Proc Bayl Univ Med Cent"},{"key":"10.1124\/jpet.121.000689_bib31","series-title":"Animal and translational models for CNS drug discovery","first-page":"223","article-title":"Development of medications for heroin and cocaine addiction and regulatory aspects of abuse liability tests","author":"Rocha","year":"2008"},{"key":"10.1124\/jpet.121.000689_bib32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2019.01.020","article-title":"Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats","volume":"150","author":"Schwienteck","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.121.000689_bib33","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3389\/fphar.2018.00654","article-title":"Pharmacotoxicology of non-fentanyl derived new synthetic opioids","volume":"9","author":"Solimini","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.121.000689_bib34","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nprot.2006.167","article-title":"Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats","volume":"1","author":"Solinas","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1124\/jpet.121.000689_bib35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00213-007-0898-5","article-title":"Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats","volume":"195","author":"Steinmiller","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.121.000689_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-2999(72)90219-1","article-title":"Studies on the quantitative antagonism of analgesics by naloxone and diprenorphine","volume":"20","author":"Takemori","year":"1972","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.121.000689_bib37","unstructured":"UNODC (2020) Global Synthetic Drugs Assessment 2020, in United Nations publication, Sales No. E.20.XI.9"},{"key":"10.1124\/jpet.121.000689_bib38","first-page":"43355","article-title":"Drug Enforcement Administration (DEA), Department of Justice, Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Final rule","volume":"73","year":"2008","journal-title":"Fed Regist"},{"key":"10.1124\/jpet.121.000689_bib39","first-page":"26349","article-title":"Drug Enforcement Administration, Department of Justice, Schedules of controlled substances: placement of acetyl fentanyl into schedule I. Final order","volume":"82","year":"2017","journal-title":"Fed Regist"},{"key":"10.1124\/jpet.121.000689_bib40","first-page":"17486","article-title":"Drug Enforcement Administration, Department of Justice, Schedules of controlled substances: placement of butyryl fentanyl and U\u201347700 into schedule I. Final order","volume":"83","year":"2018","journal-title":"Fed Regist"},{"key":"10.1124\/jpet.121.000689_bib41","series-title":"Drug Enforcement Administration, Diversion Control Division, National Forensic Laboratory Information System: NFLIS Drug 2019 Annual Report","article-title":"UNODC, An expanding synthetic drugs market - Implications for precursor control","year":"2020"},{"key":"10.1124\/jpet.121.000689_bib42","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1007\/s00204-020-02855-7","article-title":"In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances","volume":"94","author":"Vandeputte","year":"2020","journal-title":"Arch Toxicol"},{"key":"10.1124\/jpet.121.000689_bib43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4155\/fmc.13.215","article-title":"Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications","volume":"6","author":"Vardanyan","year":"2014","journal-title":"Future Med Chem"},{"key":"10.1124\/jpet.121.000689_bib44","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0022-3565(25)23869-1","article-title":"In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats","volume":"271","author":"Walker","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.000689_bib45","series-title":"WHO Expert Committee on Drug Dependence: forty-first report","year":"2019"},{"key":"10.1124\/jpet.121.000689_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/pr.112.005942","article-title":"Regulation of \u03bc-opioid receptors: desensitization, phosphorylation, internalization, and tolerance","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.121.000689_bib47","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0165-6147(92)90086-L","article-title":"Use of in vivo apparent pA2 analysis in assessment of opioid abuse liability","volume":"13","author":"Woods","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.121.000689_bib48","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fpsyt.2017.00110","article-title":"An expanding world of novel psychoactive substances: Opioids","volume":"8","author":"Zawilska","year":"2017","journal-title":"Front Psychiatry"},{"key":"10.1124\/jpet.121.000689_bib49","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s002130050035","article-title":"Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids","volume":"148","author":"Zhang","year":"2000","journal-title":"Psychopharmacology (Berl)"}],"updated-by":[{"DOI":"10.1124\/jpet.121.000689err","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000}}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524271147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524271147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.121.000689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T14:03:41Z","timestamp":1739973821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524271147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0022356524271147"],"URL":"https:\/\/doi.org\/10.1124\/jpet.121.000689","relation":{"erratum":[{"id-type":"doi","id":"10.1124\/jpet.121.000689err","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antinociceptive and Discriminative Stimulus Effects of Six Novel Psychoactive Opioid Substances in Male Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.121.000689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright.","name":"copyright","label":"Copyright"}]}}